Clincosm LogoSign in Get a demo

carcinoma, renal cell

Showing 1 - 25 of 185
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

Completed
  • Carcinoma, Renal Cell
  • We do not have any interventions. This study is based on obseravation.
  • (no location specified)
Oct 27, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +16 more
Jun 2, 2023

Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

Recruiting
  • Carcinoma, Renal Cell
  • Carcinoma, Non-Small-Cell Lung
  • Live Bacterial Product - Akkermansia muciniphila
  • Mons, Belgium
  • +3 more
May 9, 2023

Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

Recruiting
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
    • Yiwu, Zhejiang, China
      The Fourth Affiliated Hospital Zhejiang University School of Med
    Mar 27, 2023

    go Back Into Records and Observe How People With Metastatic

    Not yet recruiting
    • Carcinoma, Renal Cell
    • Clear-cell Metastatic Renal Cell Carcinoma
    • Istanbul, Turkey
      Pfizer
    Feb 15, 2023

    Three-dimensional Virtual Imaging to Improve Accuracy of

    Completed
    • Kidney Neoplasms
    • Carcinoma, Renal Cell
    • 3D-PADUA nephrometric score
    • 2D-PADUA nephrometric score
    • Orbassano, TO, Italy
      San Luigi Gonzaga Hospital
    Feb 6, 2023

    Carcinoma, Renal Cell Trial in United States (Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Boston, Massachusetts
    • +3 more
    Jan 27, 2023

    Carcinoma, Renal Cell Trial (Orellanine)

    Not yet recruiting
    • Carcinoma, Renal Cell
    • (no location specified)
    Jan 25, 2023

    Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Pembrolizumab
    • +5 more
    • New Haven, Connecticut
    • +38 more
    Jan 25, 2023

    Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Pembrolizumab
    • +5 more
    • New Haven, Connecticut
    • +37 more
    Jan 25, 2023

    Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

    Active, not recruiting
    • Carcinoma, Renal Cell
    • Tucson, Arizona
    • +147 more
    Jan 24, 2023

    Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

    Recruiting
    • Carcinoma, Renal Cell
    • Chandler, Arizona
    • +176 more
    Jan 19, 2023

    Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

    Active, not recruiting
    Has Results
    • Carcinoma
    • +7 more
    • La Jolla, California
    • +58 more
    Jan 13, 2023

    Carcinoma, Renal Cell Trial in Madison (Stereotactic Body Radiation Therapy (SBRT), Microwave Ablation (MWA))

    Active, not recruiting
    • Carcinoma, Renal Cell
    • Stereotactic Body Radiation Therapy (SBRT)
    • Microwave Ablation (MWA)
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Jan 9, 2023

    Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

    Not yet recruiting
    • Carcinoma, Renal Cell
    • Pittsburgh, Pennsylvania
      UPMC Department of Urology
    Jan 5, 2023

    NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +10 more
    • Singapore, Singapore
      Novartis Investigative Site
    Nov 16, 2022

    Immune Checkpoint Inhibitors in Genitourinary Malignancies

    Suspended
    • Carcinoma, Renal Cell
    • Carcinoma, Urothelial
    • Immune cell and CTC detection procedures
    • Durham, North Carolina
      Duke University Medical Center
    Nov 11, 2022

    Based on Evidence-based Pathological Diagnose Criteria for RCC

    Not yet recruiting
    • Carcinoma, Renal Cell
    • +3 more
    • Vascular wall invaded
    • (no location specified)
    Oct 18, 2022

    Efficacy and Safety of Avelumab + Axitinib Combination in aRCC

    Recruiting
    • Carcinoma, Renal Cell
      • Bonheiden, Belgium
      • +77 more
      Sep 16, 2022

      Among Advanced Renal Cell Carcinoma Receiving Systemic

      Not yet recruiting
      • Carcinoma, Renal Cell
        • (no location specified)
        Sep 6, 2022

        Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

        Recruiting
        • Carcinoma, Renal Cell
        • Pembrolizumab
        • +3 more
        • Birmingham, Alabama
        • +229 more
        Aug 11, 2022

        NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +3 more
        • QEQ278
        • (no location specified)
        Jul 14, 2022

        Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

        Recruiting
        • Carcinoma, Renal Cell
        • Duarte, California
        • +10 more
        Jun 13, 2022